MASS vs VRTX · rev $59.6M vs P/E 30, rev $12.00B
908 Devices Inc (MASS) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
908 Devices Inc (MASS) is a medical devices company listed on US.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported MASS revenue for 2024-12-31 was $59.6M. Net income was -$72.2M. Revenue was up 18.7% from 2023-12-31 to 2024-12-31. MASS currently screens at market cap $238.5M.
Latest reported VRTX revenue for 2025-12-31 was $12.00B. Net income was $3.95B. Revenue was up 8.9% from 2024-12-31 to 2025-12-31. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
MASS currently screens at market cap $238.5M. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the MASS and VRTX stock pages for the full models.
Not investment advice.